Mannkind (MNKD) Total Debt (2010 - 2026)
Mannkind (MNKD) posted quarterly Total Debt of $116.7 million for Q1 2026, up 24.57% year-over-year from $93.7 million in Q1 2025, and down 65.63% quarter-over-quarter from $339.5 million in Q4 2025.
Mannkind (MNKD) Total Debt (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Total Debt for 16 consecutive years, with $116.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 24.57% year-over-year to $116.7 million; the TTM figure through Mar 2026 stood at $116.7 million (up 24.57% YoY), while the FY2025 annual figure was $339.5 million, up 261.55% from the prior year.
- Total Debt retreated to $116.7 million in Q1 2026 per MNKD's latest filing, from $339.5 million in the prior quarter.
- Across five years, Total Debt topped out at $339.5 million in Q4 2025 and bottomed at $8.8 million in Q4 2022.
- Historically, Total Debt has averaged $93.3 million across 5 years, with a median of $93.8 million in 2024.
- Annual changes were most pronounced in 2023 — Total Debt soared 968.29% — and 2025, when it declined 21.89%.
- Mannkind's Total Debt stood at $8.8 million in 2022, then jumped by 968.29% to $94.3 million in 2023, then slipped by 0.44% to $93.9 million in 2024, then surged by 261.55% to $339.5 million in 2025, then sank by 65.63% to $116.7 million in 2026.
- Business Quant data shows MNKD's Total Debt at $116.7 million in Q1 2026, $339.5 million in Q4 2025, and $73.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 353.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 353.10 Mn |
| Mar 31, 2026 | 116.68 Mn |
| Dec 31, 2025 | 339.49 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Jun 30, 2025 | 93.50 Mn |
| Mar 31, 2025 | 93.67 Mn |
| Dec 31, 2024 | 93.90 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Jun 30, 2024 | 94.10 Mn |
| Dec 31, 2023 | 94.32 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Jun 30, 2019 | 80.96 Mn |
| Mar 31, 2019 | 83.42 Mn |
| Dec 31, 2018 | 83.39 Mn |
| Sep 30, 2018 | 86.35 Mn |
| Jun 30, 2018 | 110.20 Mn |
| Mar 31, 2018 | 115.90 Mn |